← Open Payments lookup

YONGZHONG WEI: Open Payments

NPI 1720227143 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$811 in 33 payments from 10 companies in 2025. Trend: 2023 $2,207 · 2024 $2,166 · 2025 $811

Food & beverage: $661Consulting: $150
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$276
Biogen, Inc.6$247
TG Therapeutics, Inc.3$69
ABBVIE INC.2$54
EMD Serono, Inc.2$54
Teva Pharmaceuticals USA, Inc.2$43
Amgen Inc.1$20
ACADIA Pharmaceuticals Inc1$20
Alexion Pharmaceuticals, Inc.1$16
PFIZER INC.1$14

Products named: KESIMPTA, TYSABRI, BRIUMVI, QULIPTA, AUSTEDO XR, UPLIZNA, NUPLAZID, ULTOMIRIS.

Industry payments across MO — which companies pay providers there.